FINWIRES · TerminalLIVE
FINWIRES

研究报告:CDW维持对CDW公司股票的买入评级。

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将目标股价从170美元下调至137美元,基于12倍的预期市盈率,我们预测2027年每股收益为11.44美元,低于该公司三年平均市盈率。我们将2026年每股收益预期从10.66美元上调至10.69美元,并将2027年每股收益预期从11.32美元上调至11.44美元。CDW公布了强劲的2026年第一季度业绩,净销售额达56.8亿美元,同比增长9.2%(按固定汇率计算增长8.4%),超出预期。营收增长主要得益于商业业务的强劲表现(增长9.6%),其中金融服务(增长28.2%)和企业业务(增长8.4%)的扩张尤为显著。然而,毛利率下降60个基点至21.0%。尽管短期内宏观经济风险较高,但管理层维持全年业绩预期,预计全年业绩将跑赢市场200-300个基点,非GAAP每股收益增长将达到中个位数的高端水平。我们还看到其他积极因素和潜在的抵消风险,包括其多元化的产品组合、积压订单和成本效益举措。我们认为,目前的估值水平也使其风险回报更具吸引力。因此,我们维持对CDW的“买入”评级。

Related Articles

Mining & Metals

WELL Health Technologies Q1 Adjusted Earnings, Revenue Beat Estimates

WELL Health Technologies (WELL.TO) Thursday after trade reported adjusted first-quarter earnings and revenue that both beat estimates.Adjusted net income, excluding most one-time items, more than doubled to $15.5 million, or $0.06 per share, from $7.5 million, or $0.03, in the prior year period. The result beat the consensus analyst estimate of $0.05 per share, according to FactSet.Revenues surged 25% to $368.3 million, beating the $366.98 million forecast. The increase was driven by organic growth, acquisitions and the inclusion of Healwell results in WELL's consolidated financial reporting, a statement said.Total patient visits rose 17% year-over-year to 1.9 million. At the end of the first quarter, WELL reported 253 clinics across Canada, including primary care, diagnostics, allied health, specialty and executive health clinics.WELL maintained its guidance for annual revenue of between $1.55 billion to $1.65 billion with adjusted EBITDA in the range of $175 million to $185 million."We are very pleased to report a strong start to 2026, with solid first quarter performance that saw our revenue run rate approach the $1.5 billion per year mark. Our Canadian clinics business continued to be a key driver of growth, achieving a revenue run rate of over half a billion dollars per year while delivering 30% year-over-year revenue growth, including 13% organic growth," said chief executive Hamed Shahbazi.Well Health shares closed up $0.03 to $4.37 on the Toronto Stock Exchange.

$WELL.TO
Australia

Trade Desk Q1 Adjusted Earnings Fall, Revenue Rises; Q2 Guidance Set

Trade Desk (TTD) reported Q1 adjusted earnings late Thursday of $0.28 per diluted share, down from $0.33 a year earlier.Analysts polled by FactSet expected $0.32.Revenue for the three months ended March 31 was $688.9 million, up from $616 million a year earlier.Analysts surveyed by FactSet expected $678.9 million.For Q2, the company expects revenue of at least $750 million. Analysts expect $771.2 million.

$TTD
Insider Trading

Datadog Insider Sold Shares Worth $2,078,550, According to a Recent SEC Filing

Kerry Acocella, General Counsel and Secretary, on May 05, 2026, sold 13,857 shares in Datadog (DDOG) for $2,078,550. Following the Form 4 filing with the SEC, Acocella has control over a total of 140,489 Class A common shares of the company, with 140,489 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1561550/000156155026000131/xslF345X05/wk-form4_1778185858.xml

$DDOG